The FDA has approved nivolumab plus platinum-doublet chemotherapy for patients with non-small cell lung cancer in the neoadjuvant setting. Nivolumab is the first immune checkpoint inhibitor to get approval for resectable NSCLC….
New Rapid Blood Test To Detect Early Stage Lung Cancer
In the arena of lung cancer, new researches and studies are being carried out all around the world to help the patients in its early detection and timely cure. One of the…
Adenocarcinoma Lung Cancer: Symptoms and Treatment
There are two predominant types of lung cancer: small cell lung cancer and non-small cell lung cancer. NSCLC accounts for about 80% to 85% of all lung cancers. Adenocarcinoma is a type…
European Commission Approves Pfizer’s Lorviqua for Advanced Lung Cancer Treatment
European Commission (EC) has granted marketing authorization for Lorviqua as monotherapy for treatment of patients with anaplastic lymphoma kinase (ALK) – positive advanced non-small cell lung cancer. Lorviqua is approved in US…
Lung Cancer Screening in Non-Smoker Women in Taiwan Associated with Overdiagnosis
A new study based on data from a National Cancer Registry in Taiwan has found that lung cancer screening may lead to overdiagnosis at the population level. The United States Preventive Services…
Sugemalimab with Chemo Demonstrates Improvement in NSCLC Survival Rates
In the year 2020, an estimate of 2.2 million people has been diagnosed with lung cancer. It is the second most commonly diagnosed cancer and is among leading cause of cancer deaths….
NICE Approves Combination Therapy for Squamous Non-Small Cell Lung Cancer
There are mainly two different groups of lung cancer: non-small cell lung cancer and small cell lung cancer. These groups can further be split into more groups depending on where and how…
Study Finds Blood Tests to help Predict Lung Cancer Screenings
According to a new study published in the Journal of Clinical Oncology, a blood test along with a risk model based on person’s history can more accurately find whether the person can…